While a surge in US bond yields has exerted upward pressure on OIS rates over the past month, market participants said that the heightened degree of vigilance about inflation expressed by the RBI on Friday had given traders reason to consider the possibility of more domestic monetary tightening.
Dr. Reddy’s Laboratories Q1 Results: PAT rises 2% YoY to Rs 1,418 crore, revenue jumps 11%
Dr Reddy’s Laboratories Q1 Results: Pharma major Dr. Reddy’s Laboratories reported a marginal 2% year-on-year (YoY) growth in its consolidated net profit at Rs 1,418